Key facts
- Heallo’s last known valuation is $10.4M (Jun 2025).
- It has raised $4.7M; the latest was Later Stage VC ($3.7M) in Jun 2025.
- Notable investors include Zest Group, AVM Gestioni SGR, Digital Magics, FoodTech Acceleration Platform, Kickstart Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Heallo
- ·The full record, as it builds
Funding rounds
No funding rounds for Heallo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heallo
Developer of a food technology designed to reduce the glycemic index in food products. The company's technology utilizes natural biotechnology to extract and concentrate functional fibers and antioxidants from plant by-products, enabling food and beverage companies to develop innovative products with high nutraceutical value, such as reduced glycemic index and potentially improved overall health benefits.
- Sector
- Business Products and Services (B2B)
- HQ
- Guardamiglio, Italy
- Founded
- 2018
- Employees
- 8
- Website
- heallosolutions.com/
- Ownership
- Privately Held (backing)
Heallo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heallo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heallo in its N-PORT filings yet. We sweep new filings monthly.